Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Different substances affect hair and skin cell growth in various ways.

New treatments for male hypogonadism are effective and should be personalized.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Growth factors are crucial for hair development and could help treat hair diseases.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

New treatments for PCOS focus on managing symptoms and improving fertility.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The document concludes that effectively managing PCOS requires a multifaceted approach.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Antibody treatments show promise for hair loss but need more research.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.